This high-resolution atlas of genetic regulation of gene expression in the human prefrontal cortex provides insight into the cell type-specific regulatory architecture of the human brain, and offers novel mechanistic targets for understanding the genetic basis of neuropsychiatric and neurodegenerative diseases.
Abstract
Genetic risk variants for common diseases are predominantly located in non-coding regulatory regions and modulate gene expression. Although bulk tissue studies have elucidated shared mechanisms of regulatory and disease-associated genetics, the cellular specificity of these mechanisms remains largely unexplored. Here we present a comprehensive, single-nucleus multi-ancestry atlas of genetic regulation of gene expression in the human prefrontal cortex, comprising 5.6 million nuclei from 1,384 donors of diverse ancestries. Through multi-resolution analyses spanning eight major cell classes and 27 subclasses, we identify genetic regulation for 14,258 genes, with 981 showing cell type-specific regulatory effects at the class level and 857 at the subclass level. Colocalization of genetic variants associated with gene regulation and disease traits uncovers novel cell type-specific genes implicated in Alzheimer’s disease, schizophrenia and other disorders that were not detectable in bulk tissue analyses. Analysis of dynamic genetic regulation at the single-nucleus level identifies 2,073 genes with regulatory effects that vary across developmental trajectories, inferred from a broad age range of donors. We also uncover 1,655 genes with trans-regulatory effects, revealing distal regulation of gene expression. This high-resolution atlas provides insight into the cell type-specific regulatory architecture of the human brain, and offers novel mechanistic targets for understanding the genetic basis of neuropsychiatric and neurodegenerative diseases. Multi-resolution genetic regulatory atlas of the human brain from single-nucleus transcriptomics of 1,384 donors of diverse ancestries reveals cell type-specific regulation underlying genetic risk of neuropsychiatric and neurodegenerative diseases.
These findings provide a cell-type-resolved and ancestry-aware atlas of genetically regulated expression in the human prefrontal cortex and illustrate how single-nucleus transcriptomics can sharpen gene discovery and therapeutic target prioritization for complex brain disorders.
S. Venkatesh, Roman Kosoy, Zhen-Yi Wu et al.· Nature· 8 citations
This study profiled gene expression and chromatin accessibility in ∼140,000 individual nuclei from 40 post-mortem adult human brain samples from 11 donors spanning four brain regions to prioritise specific neural cell populations relevant for complex traits.
Ann C. Babtie, Georgina E. T. Blake, Youth-GEMs Consortium et al.· bioRxiv· 0 citations
The findings demonstrate that the enhancer specificity across the brain provides a powerful framework for dissecting complex trait biology and revealing cellular pathology.
H. Ramcharan, Yasmine N. Sami, Kathryn E. A. Hazel et al.· bioRxiv· 0 citations
Genetic association studies have identified hundreds of largely noncoding loci associated with interindividual differences in the structure of the human cortex, although the specific functional variants contributing to these phenotypes are unknown. Here we implemented a massively parallel reporter assay to measure the...
Nana Matoba, Jessica C. McAfee, O. Krupa et al.· Nature Neuroscience· 0 citations
Most disease-associated genetic variants lie in non-coding regions1,2, yet mechanistic insights are limited by the lack of an empirical framework for characterizing the molecular consequences of regulatory variation. Single-cell molecular quantitative trait locus (QTL) mapping3,4 connects variants to gene regulation bu...
Masahiro Kanai, T. Delorey, Jarno Honkanen et al.· Nature· 2 citations
Functional dimensions of enhancer conservation are defined and how regulatory evolution shapes brain biology and disease susceptibility is revealed to reveal how regulatory evolution shapes brain biology and disease susceptibility.
Ashlyn G. Anderson, B. Rogers, Erin A. Barinaga et al.· Cell Genomics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.